• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.60% Nasdaq Down0.39%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    0.19 Down 0.00(1.58%) Feb 11, 3:59PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):3.0
    Mean Recommendation (last week):3.0
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:8.00
    Median Target:8.00
    High Target:15.00
    Low Target:1.00
    No. of Brokers:2

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Oct 21, 2015FBR CapitalDowngradeOutperformMkt Perform
    Oct 21, 2015ROTH CapitalDowngradeBuyNeutral
    Mar 12, 2014StifelDowngradeHoldSell
    Aug 30, 2012Stifel NicolausInitiated Hold
    Feb 28, 2011Canaccord GenuityUpgradeHoldBuy
    Nov 9, 2010MLV CapitalInitiated Buy
    Aug 26, 2010Morgan JosephInitiated Buy
    Feb 19, 2010RBC Capital MktsInitiated Sector Perform
    Feb 17, 2010Roth CapitalDowngradeBuyHold
    Nov 5, 2009Roth CapitalUpgradeHoldBuy

    More Upgrades & Downgrades for SNTA

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0002
    Buy0113
    Hold2220
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.